Evaluation of polymyxin B AUC/MIC ratio for dose optimization in patients with carbapenem-resistant Klebsiella pneumoniae infection

Polymyxin B has been used as a last-line therapy for the treatment of carbapenem-resistant gram-negative bacterial infection. The pharmacokinetic/pharmacodynamic index (AUC/MIC) of polymyxin B has not been clinically evaluated, given that the broth microdilution method for polymyxin susceptibility t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peile, Liu, Shaohua, Qi, Guangzhao, Xu, Min, Sun, Tongwen, Yang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477696/
https://www.ncbi.nlm.nih.gov/pubmed/37675417
http://dx.doi.org/10.3389/fmicb.2023.1226981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477696/
https://www.ncbi.nlm.nih.gov/pubmed/37675417
http://dx.doi.org/10.3389/fmicb.2023.1226981

Ejemplares similares